| 2007 | | A Case of a Rectal Teratoma | 김영배, 서광욱, 오승엽, 이광재 |
| 2011 | | Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. | 김영배, 서광욱 |
| 2017 | | Accuracy of Preoperative Local Staging of Primary Colorectal Cancer by Using Computed Tomography: Reappraisal Based on Data Collected at a Highly Organized Cancer Center | 김영배, 서광욱, 오승엽, 이제희, 정진옥 |
| 2015 | | ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer. | 김영배, 서광욱, 오승엽, 이다근, 임현이 |
| 2014 | | Clinical application of sentinel lymph node mapping in colon cancer: in vivo vs. ex vivo techniques. | 김도윤, 김영배, 서광욱, 오승엽 |
| 2013 | | Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases. | 김도윤, 김영배, 서광욱, 오승엽 |
| 2011 | | Does total mesorectal excision require a learning curve? Analysis from the database of a single surgeon's experience. | 김영배, 서광욱, 오승엽 |
| 2016 | | MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers | 김영배, 서광욱, 이다근, 이현우, 최용원 |
| 2010 | | Microsatellite Instability-low Colorectal Carcinomas: Are They Comparable with Microsatellite Stable Cancer? | 김영배, 서광욱, 오승엽 |
| 2017 | | Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer | 김영배, 서광욱, 오승엽 |
| 2013 | | Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer. | 김도윤, 김영배, 서광욱, 오승엽 |
| 2014 | | Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer. | 김도윤, 김영배, 서광욱, 오승엽, 이제희 |
| 2012 | | Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer | 김영배, 서광욱, 오승엽 |
| 2017 | | Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy | 김영배, 노오규, 서광욱, 오승엽 |
| 2017 | | Prognostic significance of systemic inflammatory response in stage II colorectal cancer | 김영배, 서광욱, 오승엽 |
| 2007 | | The Efficacy of UGT1A1 Polymorphism in Chemoradiation Therapy Using Irinotecan in Patients with Locally Advanced Rectal Cancer | 김영배, 서광욱, 오승엽, 전미선 |
| 2005 | | Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer. | 김영배, 서광욱 |
| 2009 | | Total Number of Lymph Nodes Retrieved in Stage III Rectal Cancer Patient. | 김영배, 백옥주, 서광욱, 오승엽 |
